DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
3 articles
Cardiac amyloidosis remains one of the diagnoses clinicians can miss, which is why a new AI model matters: it reads not only the heart image, but the patient context around it.
HELZ2 is not yet a new cholesterol drug, but it is a precise biological lead into how the liver decides how many atherogenic particles enter the blood.
A major international study raises the question of whether beta blockers should still be routinely prescribed after a mild heart attack in patients with preserved heart function.